#241 (Mar. 14, 2026) 'Drug Cycling in Cancer Care: What It Is and Why It’s Critical': IMA (formerly FLCCC) Weekly Update episode artwork

EPISODE · Mar 19, 2026 · 1H 15M

#241 (Mar. 14, 2026) 'Drug Cycling in Cancer Care: What It Is and Why It’s Critical': IMA (formerly FLCCC) Weekly Update

from IMA (Formerly FLCCC Alliance)

What happens when a cancer treatment stops working the way it once did? As tumors adapt and resistance develops, treatment strategy can become a critical part of improving outcomes.Sign up for weekly webinars: Weekly Webinars - Independent Medical Alliance In this episode, Dr. Ryan Cole, IMA Head of Medical & Scientific Affairs, speaks with Dr. Paul Marik, IMA Chief Scientific Officer, about the role of drug cycling in cancer care and why it may be essential for patients facing complex treatment decisions.They cover:• What drug cycling is and how it is used in cancer care• Why changing therapies over time may matter• How tumor adaptation and resistance affect treatment response• What timing, sequencing, and strategy can mean in practiceDr. Marik’s new cancer guides and how they may help support patients and familiesThis conversation offers a practical look at why cancer treatment should not always remain fixed and how thoughtful changes in therapy may help shape better outcomes.Aired Wednesday, March 18, 2026.Also:• Donate: https://imahealth.org/donate/• Follow: https://imahealth.org/contact/• Webinar: https://imahealth.org/category/weekly-webinars/• Treatment: https://imahealth.org/treatment-protocols/• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/About IMA (Formerly FLCCC Alliance)The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization’s mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.For more information about the Independent Medical Alliance, visit www.IMAhealth.org

Episode metadata supplied by the publisher feed · Published Mar 19, 2026

Embed this episode

NOW PLAYING

#241 (Mar. 14, 2026) 'Drug Cycling in Cancer Care: What It Is and Why It’s Critical': IMA (formerly FLCCC) Weekly Update

0:00 1:15:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of IMA (Formerly FLCCC Alliance)?

This episode is 1 hour and 15 minutes long.

When was this IMA (Formerly FLCCC Alliance) episode published?

This episode was published on March 19, 2026.

Can I download this IMA (Formerly FLCCC Alliance) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!